Research ArticleImmunotherapy

Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells

See allHide authors and affiliations

Science Translational Medicine  07 Aug 2013:
Vol. 5, Issue 197, pp. 197ra103
DOI: 10.1126/scitranslmed.3006034

Log in to view PDF

Log in through your institution

Log in through your institution